Blog

Leading-edge continuing medical education for doctors ensures that patients receive the best possible neuro-care. Read about the advances in the neurosciences that translate to superior care in the clinic.

Brain tumors sometimes make themselves known in baffling ways. With a trio of neurosurgeons and neuro-oncologists at his side, Rusty Doms takes a journey to new frontiers of glioblastoma treatment at the leading edge of medicine.

When a person suffers a stroke, millions of brain nerve cells die often resulting in motor disabilities such as paralysis and speech difficulties. What if researchers could challenge the brain to recover? That's what PNI researchers are doing for patients up to 7 1/2 years after their attack.

August 2017: The Lancet OncologyRindopepimut with temozolomide for patients with newly diagnosed, EGFRvIII-expressing glioblastoma (ACT IV): a randomised, double-blind, international phase 3 trial. August 2017: Nature NeuroscienceA TNF-JNK-Axl-ERK signaling axis mediates primary resistance to EGFR inhibition in glioblastoma. May 2017: International Journal of Molecular SciencesBiomarker...

The movement disorders program at Providence Saint John’s Health Center is expanding, offering patients a full range of diagnostic, treatment and supportive services, including a new Parkinson’s disease patient support group and access to evidence-based physical therapy.

This month, the Pacific Movement Disorders Center is focused on boosting awareness of dystonia. Take an in-depth tour of dystonia and find out what you need to know about this group of neurological disorders.

SANTA MONICA (September 1, 2017) – Pacific Neuroscience Institute announced today the launch of PNI Medical Group's affiliation with Providence Saint John’s Health Clinic.